Skip to Content

M O17 (Oxybutynin Chloride Extended Release 15 mg)

Pill with imprint M O17 is Gray, Round and has been identified as Oxybutynin Chloride Extended Release 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M O17

Oxybutynin chloride extended release 15 mg M O17
Oxybutynin chloride extended release 15 mg M O17  Front
Oxybutynin chloride extended release 15 mg M O17  Back
Oxybutynin chloride extended release 15 mg M O17

Oxybutynin Chloride Extended Release

Imprint
M O17
Strength
15 mg
Color
Gray
Size
8.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-6015 Mylan Pharmaceuticals Inc.
54868-5743 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "M O17"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.